Report Detail

Request for Sample of this report

Medical Industry Global Antisense Oligonucleotides Market Size, Status and Forecast 2020-2026

  • RnM3941806
    • |
  • 01 April, 2020
    • |
  • Global
    • |
  • 125 Pages
    • |
  • HJResearch
    • |
  • Medical Industry

Antisense oligonucleotides (ASOs) are 15–25 nt oligonucleotides designed to tie complementary RNA targets for the degradation. They are synthesized so that they can be used to block disease processes by altering the synthesis of a specific protein.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Antisense Oligonucleotides market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Antisense Oligonucleotides industry.
Based on our recent survey, we have several different scenarios about the Antisense Oligonucleotides YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Antisense Oligonucleotides will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antisense Oligonucleotides market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antisense Oligonucleotides market in terms of revenue.
Players, stakeholders, and other participants in the global Antisense Oligonucleotides market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Antisense Oligonucleotides market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Antisense Oligonucleotides market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antisense Oligonucleotides market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antisense Oligonucleotides market.
The following players are covered in this report:
Ionis Pharmaceuticals
Sarepta Therapeutics
Biogen
Alnylam Pharmaceuticals
Antisense Therapeutics
Isarna Therapeutics
Arrowhead Pharmaceuticals
Atlantic Pharmaceuticals
Enzon Pharmaceuticals
Bio-Path Holdings
GlaxoSmithKline
Geron
ICO Therapeutics
Marina Biotech
RXi Pharmaceuticals
Antisense Oligonucleotides Breakdown Data by Type
RNA Antisense Oligonucleotides
DNA Antisense Oligonucleotides
Antisense Oligonucleotides Breakdown Data by Application
Hospitals
Clinic
Others


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Antisense Oligonucleotides Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Antisense Oligonucleotides Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 RNA Antisense Oligonucleotides
    • 1.4.3 DNA Antisense Oligonucleotides
  • 1.5 Market by Application
    • 1.5.1 Global Antisense Oligonucleotides Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Clinic
    • 1.5.4 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Antisense Oligonucleotides Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Antisense Oligonucleotides Industry
      • 1.6.1.1 Antisense Oligonucleotides Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Antisense Oligonucleotides Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Antisense Oligonucleotides Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Antisense Oligonucleotides Market Perspective (2015-2026)
  • 2.2 Antisense Oligonucleotides Growth Trends by Regions
    • 2.2.1 Antisense Oligonucleotides Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Antisense Oligonucleotides Historic Market Share by Regions (2015-2020)
    • 2.2.3 Antisense Oligonucleotides Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Antisense Oligonucleotides Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Antisense Oligonucleotides Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Antisense Oligonucleotides Players by Market Size
    • 3.1.1 Global Top Antisense Oligonucleotides Players by Revenue (2015-2020)
    • 3.1.2 Global Antisense Oligonucleotides Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Antisense Oligonucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Antisense Oligonucleotides Market Concentration Ratio
    • 3.2.1 Global Antisense Oligonucleotides Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Antisense Oligonucleotides Revenue in 2019
  • 3.3 Antisense Oligonucleotides Key Players Head office and Area Served
  • 3.4 Key Players Antisense Oligonucleotides Product Solution and Service
  • 3.5 Date of Enter into Antisense Oligonucleotides Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Antisense Oligonucleotides Historic Market Size by Type (2015-2020)
  • 4.2 Global Antisense Oligonucleotides Forecasted Market Size by Type (2021-2026)

5 Antisense Oligonucleotides Breakdown Data by Application (2015-2026)

  • 5.1 Global Antisense Oligonucleotides Market Size by Application (2015-2020)
  • 5.2 Global Antisense Oligonucleotides Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Antisense Oligonucleotides Market Size (2015-2020)
  • 6.2 Antisense Oligonucleotides Key Players in North America (2019-2020)
  • 6.3 North America Antisense Oligonucleotides Market Size by Type (2015-2020)
  • 6.4 North America Antisense Oligonucleotides Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Antisense Oligonucleotides Market Size (2015-2020)
  • 7.2 Antisense Oligonucleotides Key Players in Europe (2019-2020)
  • 7.3 Europe Antisense Oligonucleotides Market Size by Type (2015-2020)
  • 7.4 Europe Antisense Oligonucleotides Market Size by Application (2015-2020)

8 China

  • 8.1 China Antisense Oligonucleotides Market Size (2015-2020)
  • 8.2 Antisense Oligonucleotides Key Players in China (2019-2020)
  • 8.3 China Antisense Oligonucleotides Market Size by Type (2015-2020)
  • 8.4 China Antisense Oligonucleotides Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Antisense Oligonucleotides Market Size (2015-2020)
  • 9.2 Antisense Oligonucleotides Key Players in Japan (2019-2020)
  • 9.3 Japan Antisense Oligonucleotides Market Size by Type (2015-2020)
  • 9.4 Japan Antisense Oligonucleotides Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Antisense Oligonucleotides Market Size (2015-2020)
  • 10.2 Antisense Oligonucleotides Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Antisense Oligonucleotides Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Antisense Oligonucleotides Market Size by Application (2015-2020)

11 India

  • 11.1 India Antisense Oligonucleotides Market Size (2015-2020)
  • 11.2 Antisense Oligonucleotides Key Players in India (2019-2020)
  • 11.3 India Antisense Oligonucleotides Market Size by Type (2015-2020)
  • 11.4 India Antisense Oligonucleotides Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Antisense Oligonucleotides Market Size (2015-2020)
  • 12.2 Antisense Oligonucleotides Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Antisense Oligonucleotides Market Size by Type (2015-2020)
  • 12.4 Central & South America Antisense Oligonucleotides Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Ionis Pharmaceuticals
    • 13.1.1 Ionis Pharmaceuticals Company Details
    • 13.1.2 Ionis Pharmaceuticals Business Overview and Its Total Revenue
    • 13.1.3 Ionis Pharmaceuticals Antisense Oligonucleotides Introduction
    • 13.1.4 Ionis Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2015-2020))
    • 13.1.5 Ionis Pharmaceuticals Recent Development
  • 13.2 Sarepta Therapeutics
    • 13.2.1 Sarepta Therapeutics Company Details
    • 13.2.2 Sarepta Therapeutics Business Overview and Its Total Revenue
    • 13.2.3 Sarepta Therapeutics Antisense Oligonucleotides Introduction
    • 13.2.4 Sarepta Therapeutics Revenue in Antisense Oligonucleotides Business (2015-2020)
    • 13.2.5 Sarepta Therapeutics Recent Development
  • 13.3 Biogen
    • 13.3.1 Biogen Company Details
    • 13.3.2 Biogen Business Overview and Its Total Revenue
    • 13.3.3 Biogen Antisense Oligonucleotides Introduction
    • 13.3.4 Biogen Revenue in Antisense Oligonucleotides Business (2015-2020)
    • 13.3.5 Biogen Recent Development
  • 13.4 Alnylam Pharmaceuticals
    • 13.4.1 Alnylam Pharmaceuticals Company Details
    • 13.4.2 Alnylam Pharmaceuticals Business Overview and Its Total Revenue
    • 13.4.3 Alnylam Pharmaceuticals Antisense Oligonucleotides Introduction
    • 13.4.4 Alnylam Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2015-2020)
    • 13.4.5 Alnylam Pharmaceuticals Recent Development
  • 13.5 Antisense Therapeutics
    • 13.5.1 Antisense Therapeutics Company Details
    • 13.5.2 Antisense Therapeutics Business Overview and Its Total Revenue
    • 13.5.3 Antisense Therapeutics Antisense Oligonucleotides Introduction
    • 13.5.4 Antisense Therapeutics Revenue in Antisense Oligonucleotides Business (2015-2020)
    • 13.5.5 Antisense Therapeutics Recent Development
  • 13.6 Isarna Therapeutics
    • 13.6.1 Isarna Therapeutics Company Details
    • 13.6.2 Isarna Therapeutics Business Overview and Its Total Revenue
    • 13.6.3 Isarna Therapeutics Antisense Oligonucleotides Introduction
    • 13.6.4 Isarna Therapeutics Revenue in Antisense Oligonucleotides Business (2015-2020)
    • 13.6.5 Isarna Therapeutics Recent Development
  • 13.7 Arrowhead Pharmaceuticals
    • 13.7.1 Arrowhead Pharmaceuticals Company Details
    • 13.7.2 Arrowhead Pharmaceuticals Business Overview and Its Total Revenue
    • 13.7.3 Arrowhead Pharmaceuticals Antisense Oligonucleotides Introduction
    • 13.7.4 Arrowhead Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2015-2020)
    • 13.7.5 Arrowhead Pharmaceuticals Recent Development
  • 13.8 Atlantic Pharmaceuticals
    • 13.8.1 Atlantic Pharmaceuticals Company Details
    • 13.8.2 Atlantic Pharmaceuticals Business Overview and Its Total Revenue
    • 13.8.3 Atlantic Pharmaceuticals Antisense Oligonucleotides Introduction
    • 13.8.4 Atlantic Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2015-2020)
    • 13.8.5 Atlantic Pharmaceuticals Recent Development
  • 13.9 Enzon Pharmaceuticals
    • 13.9.1 Enzon Pharmaceuticals Company Details
    • 13.9.2 Enzon Pharmaceuticals Business Overview and Its Total Revenue
    • 13.9.3 Enzon Pharmaceuticals Antisense Oligonucleotides Introduction
    • 13.9.4 Enzon Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2015-2020)
    • 13.9.5 Enzon Pharmaceuticals Recent Development
  • 13.10 Bio-Path Holdings
    • 13.10.1 Bio-Path Holdings Company Details
    • 13.10.2 Bio-Path Holdings Business Overview and Its Total Revenue
    • 13.10.3 Bio-Path Holdings Antisense Oligonucleotides Introduction
    • 13.10.4 Bio-Path Holdings Revenue in Antisense Oligonucleotides Business (2015-2020)
    • 13.10.5 Bio-Path Holdings Recent Development
  • 13.11 GlaxoSmithKline
    • 10.11.1 GlaxoSmithKline Company Details
    • 10.11.2 GlaxoSmithKline Business Overview and Its Total Revenue
    • 10.11.3 GlaxoSmithKline Antisense Oligonucleotides Introduction
    • 10.11.4 GlaxoSmithKline Revenue in Antisense Oligonucleotides Business (2015-2020)
    • 10.11.5 GlaxoSmithKline Recent Development
  • 13.12 Geron
    • 10.12.1 Geron Company Details
    • 10.12.2 Geron Business Overview and Its Total Revenue
    • 10.12.3 Geron Antisense Oligonucleotides Introduction
    • 10.12.4 Geron Revenue in Antisense Oligonucleotides Business (2015-2020)
    • 10.12.5 Geron Recent Development
  • 13.13 ICO Therapeutics
    • 10.13.1 ICO Therapeutics Company Details
    • 10.13.2 ICO Therapeutics Business Overview and Its Total Revenue
    • 10.13.3 ICO Therapeutics Antisense Oligonucleotides Introduction
    • 10.13.4 ICO Therapeutics Revenue in Antisense Oligonucleotides Business (2015-2020)
    • 10.13.5 ICO Therapeutics Recent Development
  • 13.14 Marina Biotech
    • 10.14.1 Marina Biotech Company Details
    • 10.14.2 Marina Biotech Business Overview and Its Total Revenue
    • 10.14.3 Marina Biotech Antisense Oligonucleotides Introduction
    • 10.14.4 Marina Biotech Revenue in Antisense Oligonucleotides Business (2015-2020)
    • 10.14.5 Marina Biotech Recent Development
  • 13.15 RXi Pharmaceuticals
    • 10.15.1 RXi Pharmaceuticals Company Details
    • 10.15.2 RXi Pharmaceuticals Business Overview and Its Total Revenue
    • 10.15.3 RXi Pharmaceuticals Antisense Oligonucleotides Introduction
    • 10.15.4 RXi Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2015-2020)
    • 10.15.5 RXi Pharmaceuticals Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Summary:
    Get latest Market Research Reports on Antisense Oligonucleotides. Industry analysis & Market Report on Antisense Oligonucleotides is a syndicated market report, published as Global Antisense Oligonucleotides Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Antisense Oligonucleotides market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,500.00
    		$7,000.00
    		2,810.50
    		5,621.00
    		3,283.00
    		6,566.00
    		540,505.00
    		1,081,010.00
    		292,740.00
    		585,480.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo